GPC/SEC
IndustriesPharma & Biopharma
ManufacturerAgilent Technologies
Significance of the Topic
Insulin is widely used for diabetes treatment. Accurate measurement of high molecular weight aggregates is critical for safety and efficacy of therapeutic preparations. Aggregation can reduce potency and increase immunogenic risk. The standard pharmacopoeial methods rely on size exclusion chromatography but suffer from long analysis times and limited resolution.
Objectives and Study Overview
This study evaluates a high performance size exclusion chromatography method based on an Agilent AdvanceBio SEC column with 120 angstrom pore size and sub two micrometer particles. The goal is to compare resolution and analysis speed with traditional pharmacopoeial methods and competitor columns.
Methodology
The developed method uses a mobile phase of arginine acetic acid and acetonitrile in a 65 15 20 volume ratio. Chromatographic parameters include a flow rate of 0.3 mL per minute a column temperature of 25 degrees Celsius and an injection volume of 2 microliters. Total run time is 15 minutes. Samples comprise native insulin standard and heat stressed insulin incubated at 60 degrees Celsius for six hours.
Instrumentation
- Agilent 1260 Infinity II Bio inert LC system
- Bio inert pump module
- Multisampler with sample cooler
- Multicolumn thermostat with bio inert heat exchanger
- Variable wavelength detector
- Agilent AdvanceBio SEC column 1.9 micrometer 120 angstrom 4.6 by 300 millimeter
Main Results and Discussion
The AdvanceBio SEC column achieved a resolution of 4.03 between monomer and high molecular weight species exceeding the pharmacopoeial requirement of at least 2.0. Peak tailing and width were improved. Analysis time was reduced from 35 to 15 minutes. In comparison with two competitor columns operating under similar conditions the Agilent column provided more than 50 percent higher resolution and better separation of low molecular weight fragments and aggregates. Quantification of aggregates in heat stressed samples was more accurate and reproducible.
Benefits and Practical Applications
- Significant reduction in analysis time enables high throughput quality control
- Enhanced resolution improves quantification of insulin aggregates and low molecular weight fragments
- Hydrophilic polymer coating minimizes secondary interactions
- Lower solvent consumption reduces operational costs and environmental impact
Future Trends and Applications
Adoption of sub two micrometer particle technology in official monograph methods can modernize routine assays. Integration with automation and advanced data analysis supports real time monitoring of protein stability. Coupling with multi angle light scattering or mass spectrometry can offer deeper characterization of aggregate species and aid biotherapeutic development.
Conclusion
The high performance SEC method using the AdvanceBio SEC 120 angstrom sub two micrometer column delivers significant improvements in resolution and speed for insulin aggregate analysis. These advances support reliable quality control of therapeutic insulin with reduced cost and increased laboratory throughput.
References
- Yang Y et al An Achilles Heel in an Amyloidogenic Protein and Its Repair Insulin Fibrillation and Therapeutic Design Journal of Biological Chemistry 2010 10806 10821
- Librizzi F Rischel The Kinetic Behavior of Insulin Fibrillation is Determined by Heterogeneous Nucleation Pathways Protein Science 2005 12 3129 3134
- United States Pharmacopeia Insulin Monograph Pharmacopeial Forum 31 5 1375
- European Pharmacopeia Human Insulin Monograph 5 0 2005 838 1800 1802
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.